Scientists have found a new way to stop cancer growth without damaging healthy cells. Researchers from the Francis Crick ...

Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...

Vividion Therapeutics, Inc. (Vividion), a clinical-stage biopharmaceutical company, and a wholly owned and independently operated subsidiary of Bayer AG, today announced the publication of a ...

When the lungs are attacked by a virus, the damage doesn't stop there. The body's natural defenses cause inflammation while fighting the virus, often leaving lasting problems. The cells that make up ...